Starton Therapeutics
Biotechnology, 215 College Rd, Paramus, New Jersey, 07652, United States, 11-50 Employees
Who is STARTON THERAPEUTICS
Starton Therapeutics is a clinical-stage biotechnology company that is transforming standard-of-care therapies with proprietary dermal technology, so people with cancer can receive contin...
Read More
-
Headquarters: 215 College Rd, Paramus, New Jersey, 07652, United States
-
Date Founded: 2017
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 7389
Does something look wrong? Fix it. | View contact records from STARTON THERAPEUTICS
Starton Therapeutics Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Starton Therapeutics
Answer: Starton Therapeutics's headquarters are located at 215 College Rd, Paramus, New Jersey, 07652, United States
Answer: Starton Therapeutics's official website is https://startontx.com
Answer: Starton Therapeutics's revenue is $1 Million to $5 Million
Answer: Starton Therapeutics's SIC: 7389
Answer: Starton Therapeutics has 11-50 employees
Answer: Starton Therapeutics is in Biotechnology
Answer: Starton Therapeutics contact info: Phone number: Website: https://startontx.com
Answer: Starton Therapeutics is a clinical-stage biotechnology company that is transforming standard-of-care therapies with proprietary dermal technology, so people with cancer can receive continuous treatment to live better, longer. Chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) are the most common blood cancers in the United States. There is no treatment to help people with CLL to stay in remission, and while advances in treatment have provided people with MM a multitude of treatment options, they struggle with long-term tolerance of high doses, which may be more effective but come with a multitude of side effects. Startons team of some of the best in clinical development and hematology/oncology have come together to change the fate for people struggling with the impact of their diseases. If dose-related side effects can be reduced and people can tolerate maintenance therapy for decades to help stay in remission, these cancers which were previously a death sentence would become more akin to chronic diseases, with a long lifespan and healthy quality of life. Starton is one of the few life sciences companies funded exclusively by individual investors. We have a business model that is lower risk, faster to market and less capital intensive than biotech companies developing medicines from scratch.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month